Abstract:Objective To evaluate effects of celecoxib (a selective cox-2 inhibitor)combined with fluvastatin (a HMG-CoA reductase inhibitor) on tumor growth and cell apoptosis in hepatocellular carcinoma xenograft in nude mice. Methods Hepatocellular carcinoma BEL-7402 cells were inoculated subcutaneously into the left armpit of nude mice, the mice (n = 32) were then randomly divided into 4 groups: the control group, the celecoxib group,the fluvastatin group and the combination group. At the end of the study,Tumor Tissues were collected for analysis. Cell apoptosis was determined by flow cytometry analysis and TUNEL assay. Akt, p-Akt and survivin protein levels were measured by Western blot. Statistical comparisons were made using factorial analysis of variance (ANOVA) and multiple comparisons between each two groups were calculated using SNK-q test. Results The combination of Celecoxib and fluvastatin resulted in a greater inhibition of tumor growth than either agent alone, the tumor inhibitory rate was 34.0% in the Celecoxib group, 25.0% in the fluvastatin group and 72.2% in the combination group. The percentages of TUNEL--positive cancer cells in the celecoxib and fluvastatin alone treatment groups were 8.5% ± 1.4% and 9.4% ±1.7% respectively as compared to the control group which was 3.5% ± 0.8%. Combination therapy showed a significantly greater increase in tumor cell apoptosis in comparison with the control and single-therapy groups (apoptotic index: 19.4% ± 3.0%; P ＜ 0.01 versus celecoxib or fluvastatin groups). The results of flow cytometry analysis also showed the same tendency. a small number of apoptotic cells were detected in the control tumours (4.1% ± 1.6%), whereas a large number of apoptotic cells were detected in tumours treated with celecoxib (9.1% ± 2.1%) or fluvastatin (10.1% ± 2.3%) alone; and the combination therapy resulted in even more apoptotic cells (23.6% ± 5.8%; P ＜ 0.01 versus celecoxib or fluvastatin groups). Western blot analysis demonstrated that the combination of celecoxib and fluvastatin significantly down-regulated p-Akt (0.23 ± 0.08 versus 1.12 ± 0.07 and surviving (0.50 ± 0.07 versus 1.47 ± 0.19) in BEL-7402 tumours compared with the control (P ＜ 0.01 for all). Conclusion The present study provided evidence that treatment with celecoxib in combination with fluvastatin resulted in the inhibition of HCC tumour growth in an in vivo mouse model. Key words: Carcinoma, hepatocellular; Mice, nude; Apoptosis; Celecoxib; Fluvastatin

Combinational chemoprevention effect of celecoxib and an oral antiangiogenic LHD4 on colorectal carcinogenesis in mice

[Effect of Selective Cyclooxygenase-2 Inhibitor Celebrex on Expression of Vascular Endothelial Growth Factor (VEGF) in Pancreatic Carcinoma].

Effect of celecoxib on hepatic and renal functions in rats with mammary carcinoma

Celecoxib in the Histological Grade of Chemically Induced Mammary Tumor in Rats

The chemopreventive effect of celecoxib on DMBA-chemically induced breast cancer

Efficacy and Safety Profile of Celecoxib for Treating Advanced Cancers: A Meta-Analysis of 11 Randomized Clinical Trials

[Chemopreventive Effect of Celecoxib Against DMBA-induced Breast Cancer and Its Mechanism].

Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo

Effect Of Celecoxib Combined With Chemotherapy Drug On Malignant Biological Behaviors Of Gastric Cancer

[Chemopreventive Effect of Tamoxifen Combined with Celecoxib on DMBA-induced Breast Cancer in Rats].

ADT-OH Synergistically Enhanced the Antitumor Activity of Celecoxib in Human Colorectal Cancer Cells.

Effects of Genetic and Pharmacologic Inhibition of COX-2 on Colitis-associated Carcinogenesis in Mice

Abstract LB377: The combination of epigallocatechin gallate (EGCG) and resveratrol prevents 4-NQO-induced oral carcinogenesis in mice

Chemopreventive effect of cyclooxygenase-2 specific inhibitor on chemically induced breast cancer in rats

PC‐407, a Celecoxib Derivative, Inhibited the Growth of Colorectal Tumor in Vitro and in Vivo

Inhibitory Effects of Celecoxib on DMBA-chemically Induced Breast Cancer and the Mechanism

Chemopreventive effects of celecoxib on rat colon aberrant crypt foci induced by dimethylhydrazine

[CHL Prevent Colon Neoplasms in Mice and Its Selective Inhibition on COX-2].

An Apple Oligogalactan Potentiates the Growth Inhibitory Effect of Celecoxib on Colorectal Cancer

Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum

Effects of celecoxib combined with fluvastatin on tumor growth and cell apoptosis in a xenograft model of hepatocellular carcinoma